BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10444237)

  • 1. Cardiovascular profile of loratadine.
    Hey JA; Affrime M; Cobert B; Kreutner W; Cuss FM
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():197-9. PubMed ID: 10444237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of oocytes and runny noses.
    Rosen MR
    Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing the cardiac safety of ebastine. Epilogue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():89-92. PubMed ID: 10597871
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the cardiac safety of second-generation antihistamines.
    Taglialatela M; Annunziato L
    Allergy; 2000; 55 Suppl 60():22-30. PubMed ID: 10887972
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
    Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
    Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
    Leurs R; Church MK; Taglialatela M
    Clin Exp Allergy; 2002 Apr; 32(4):489-98. PubMed ID: 11972592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drugs, HERG, and the heart.
    Hancox JC; Witchel HJ
    Lancet; 2000 Jul; 356(9227):428. PubMed ID: 10972395
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital and acquired long QT syndrome.
    Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
    Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular diagnosis and treatment of cardiovascular diseases.
    Duff HJ
    Can J Cardiol; 2000 Mar; 16(3):304-6. PubMed ID: 10744791
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
    Suessbrich H; Waldegger S; Lang F; Busch AE
    FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
    Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
    Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.
    Pearlstein R; Vaz R; Rampe D
    J Med Chem; 2003 May; 46(11):2017-22. PubMed ID: 12747773
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiology of EAG K+ channels.
    Bauer CK; Schwarz JR
    J Membr Biol; 2001 Jul; 182(1):1-15. PubMed ID: 11426295
    [No Abstract]   [Full Text] [Related]  

  • 14. The long QT syndrome.
    Priori SG; Bloise R; Crotti L
    Europace; 2001 Jan; 3(1):16-27. PubMed ID: 11271945
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
    Anderson ME; Al-Khatib SM; Roden DM; Califf RM;
    Am Heart J; 2002 Nov; 144(5):769-81. PubMed ID: 12422144
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etiological mechanism of long QT syndrome and the effects of macrolides].
    Kato T
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():118-22. PubMed ID: 11439888
    [No Abstract]   [Full Text] [Related]  

  • 17. A sensitive mechanism for cation modulation of potassium current.
    Numaguchi H; Johnson JP; Petersen CI; Balser JR
    Nat Neurosci; 2000 May; 3(5):429-30. PubMed ID: 10769379
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular cardiology. Ion channels lose the rhythm.
    Welsh MJ; Hoshi T
    Nature; 1995 Aug; 376(6542):640. PubMed ID: 7651510
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome.
    Van Langen IM; Birnie E; Alders M; Jongbloed RJ; Le Marec H; Wilde AA
    J Med Genet; 2003 Feb; 40(2):141-5. PubMed ID: 12566525
    [No Abstract]   [Full Text] [Related]  

  • 20. Potassium and long QT syndrome: a new look at an old therapy.
    Bisinov E; Mitchell JH; January CT
    J Am Coll Cardiol; 2003 Nov; 42(10):1783-4. PubMed ID: 14642688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.